| 1 |
Salix Pharmaceuticals, Inc et al v. Taro Pharmaceutical U.S.A., Inc. et al |
1:15-cv-07980 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 2 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
| 3 |
Salix Pharmaceuticals, Ltd. et al v. Actavis Laboratories FL, Inc. |
1:16-cv-00188 |
D.Del. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 4 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al |
2:17-cv-06714 |
D.N.J. |
|
|
|
|
| 5 |
BAUSCH HEALTH COMPANIES INC et al v. GLAND PHARMA LIMITED |
2:22-cv-00939 |
D.N.J. |
|
|
|
|
| 6 |
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc. |
1:24-cv-00036 |
N.D.W.Va. |
|
|
|
|
| 7 |
BAUSCH HEALTH IRELAND LIMITED et al v. MSN LABORATORIES PRIVATE LTD. et al |
2:24-cv-07182 |
D.N.J. |
|
|
|
|
| 8 |
SALIX PHARMACEUTICALS, INC. et al v. CIPLA USA, INC. et al |
1:24-cv-10213 |
D.N.J. |
|
|
|
|
| 9 |
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc. |
1:25-cv-00003 |
N.D.W.Va. |
|
|
|
|
